This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Although the life sciences firms blend of knowledge-driven resources and AI placed it at the forefront of drug discovery innovation, Egorov identified a critical vulnerability: the companys model depended too heavily on a small set of major pharmaceutical customers, leaving its growth in the hands of external decision-makers.
A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. One company we spoke to–a $110M equipment leasing firm–has been looking for a way out of this Excel mess for three years.
As an investor, since 1969, I had to work through audited financial statements. I was appointed at Unisa School for Business Leadership to teach MBL Financial Management in 2008, after that I did my CFO(SA) as it was related. Can you share some career highlights and defining moments?
Pharmaceutical companies also have to rethink how they approach vendor onboarding, with many finding that it is no longer safe or possible to visit potential manufacturing partners in person for on-site tours and inspections. This can reduce workloads and accelerate processes for the buyers.
Real-time access to tracking data through distributed ledger technology is critical for time-sensitive materials, such as pharmaceuticals or [foods]. Across treasury and supply chain efforts, Rodrigues noted, blockchain can help improve risk management through three major points: data redundancy, auditability and smart-contract permissions.
Mile High Labs is using Chain.io’s platform, a blockchain solution called Vault, to provide proof of authorization and auditing documents. “In more traditional industries, such as food production and pharmaceuticals , there are legacy systems and long-established ways of thinking,” said Chain.io
In South Africa, we seem to apply IAS 38 with extra caution—thanks in part to our regulatory environment , where bodies like the Independent Regulatory Board for Auditors (IRBA) enforce stringent controls on audit firms that forces them to favour conservatism over practical considerations to avoid fines and penalties from the IRBA.
The lack of uniform controls across these applications can result in inconsistent, non-conforming access, time-intensive and error-prone monitoring, increased threats, fraud, and audit deficiencies. Vitasoy group director for internal audit and risk management Terence Chow commented that it's more than just financial data.
In addition, the technology can boost information and money flow, improve auditability and streamline processes. The companies pointed out that blockchain can minimize fraud for importers and exporters, banks and financial institutions, insurers and export credit agencies, government agencies and service providers.
Michaels, who is a director at Soluna and chairs the audit committee, brings more than a decade of CFO experience, including his ten-year tenure at the American Institute for Economic Research. The change was effective from April 21, following the decision of the current CFO, Philip Patman Jr.,
Anti-fraud software Berbix also pitched, as did Dataform, a data management company targeting the pharmaceutical space. Mutiny is a startup helping other B2B Software-as-a-Service (SaaS) companies create better websites, while Sterblue has developed software that empowers drones to inspect large outdoor structures. “We
The Accountant-General’s Department handles finances, payroll, claims and internal audits for Singapore Civil Service. This increased the granular analysis that finance staff can undertake and facilitated more targeted and in-depth audits for our client agencies.”.
A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. One company we spoke to–a $110M equipment leasing firm–has been looking for a way out of this Excel hell for three years.
We don’t know what do we need to do to make sure we pass our next audit? So, you mentioned earlier the SEC, and I think I brought up audits, pre-pandemic, the rule of thumb was, hey, expect an audit every three years, and then the pandemic happened, and for three years, you know, everybody was sort of frozen.
We organize all of the trending information in your field so you don't have to. Join 39,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content